12 trends to be witnessed in 2019 : Pharma Outlook
What does 2019 have in store for Pharma? It was asked to industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead.
8. Robust Growth for China's Biopharma Market
Will pricing pressure lead to a shift in budget management? Is this the year for biosimilar approvals? Will we see continued M&A activity in the sector?
From life cycle management to AI, and Supergenerics to digital healthcare, listed are the Pharma and Biopharma trends about 2019.
1. Big Pharma Restructuring will Create Challenges and Opportunities
Jim Miller, Former President & Founder, PharmSource
2. Continued M&A in the CDMO and CMO Business Sector
Kevin Bottomley, Partner, Results Healthcare
3. 2019: The Year of AI
Gunjan Bhardwaj, CEO, Innoplexus
4. A Paradigm Shift in the Management of Pharmaceutical Budgets
Maarten Van Baelen, Market Access Director, Medicines for Europe
5. Value Added Medicines: Digital Healthcare to the Rescue
Aurelio Arias, Senior Consultant - European Thought Leadership, IQVIA
6. Industry 4.0 and Biopharma
Killian O’Driscoll, Director of Projects, NIBRT
7. Life Cycle Management
Alan Sheppard, Managing Director, Ascher Resources
8. Robust Growth for China's Biopharma Market
Vicky Xia, BioPlan Associates
9. Better Treatments Through a Deeper Understanding of Patients’ Needs
Will Downie, Senior Vice President, Global Sales & Marketing, Catalent Pharma Solutions
10. Industry-Wide Consolidation
Brandon Boyd, Director, Strategy & Thought Leadership - Life Sciences, Clarivate Analytics
11. A Big Year for Biosimilar Approvals
Fiona Barry, Associate Editor, PharmSource, a GlobalData product
12. Supergenerics with the Potential to Outperform New Chemical Entities
Paul Thorning, CEO, Crystec Pharma
Comments
Post a Comment